Boundless Bio Market Cap

Boundless Bio has a market cap or net worth of $201.27 million as of May 3, 2024.

Market Cap

201.27M

Enterprise Value

82.15M

1-Year Change

n/a

Ranking

#3592

Market Cap Chart

Since the IPO on March 28, 2024, Boundless Bio's market cap has decreased from $355.83M to $201.27M, a decrease of -43.44%.

Market Cap History

Date	Market Cap	% Change
May 1, 2024	222.40M	1.00%
Apr 30, 2024	220.20M	-13.61%
Apr 29, 2024	254.90M	-1.55%
Apr 26, 2024	258.90M	-3.54%
Apr 25, 2024	268.40M	9.42%
Apr 24, 2024	245.30M	3.46%
Apr 23, 2024	237.10M	6.51%
Apr 22, 2024	222.60M	-0.80%
Apr 19, 2024	224.40M	-10.70%
Apr 18, 2024	251.30M	0.08%
Apr 17, 2024	251.10M	6.94%
Apr 16, 2024	234.80M	-2.17%
Apr 15, 2024	240.00M	-4.42%
Apr 12, 2024	251.10M	-2.90%
Apr 11, 2024	258.60M	-2.05%
Apr 10, 2024	264.00M	-1.09%
Apr 9, 2024	266.90M	-3.68%
Apr 8, 2024	277.10M	-5.75%
Apr 5, 2024	294.00M	1.69%
Apr 4, 2024	289.10M	-3.34%
Apr 3, 2024	299.10M	-1.25%
Apr 2, 2024	302.90M	0.60%
Apr 1, 2024	301.10M	-15.38%
Mar 28, 2024	355.83M	-

View and export this data all the way back to 2024. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Actinium Pharmaceuticals	226.35M
Coherus BioSciences	222.46M
Conduit Pharmaceuticals	222.23M
Ventyx Biosciences	221.60M
INmune Bio	221.40M
Adlai Nortye	217.83M
Galectin Therapeutics	217.28M
AVITA Medical	216.72M

Market Cap Rankings